Kathleen Weisel
Impact in
-
- Psoriasis: Treatment and Pathogenesis
- interferon and immune responses
- Phagocytosis and Immune Regulation
- Immune Response and Inflammation
-
- Inflammatory Bowel Disease
Papers in
-
- Immunodeficiency and Autoimmune Disorders 4
- Psoriasis: Treatment and Pathogenesis 2
- T-cell and B-cell Immunology 1
- Co-authors
- Debra Tompson (3 shared papers)John Bertin (2 shared papers)Paul P. Tak (2 shared papers)Monica Simeoni (2 shared papers)Scott B. Berger (2 shared papers)Nicola Scott (2 shared papers)Zijiang Yang (6 shared papers)Mary Ellen Frustaci (6 shared papers)
- Journals
- Gastroenterology (2 papers)Journal of Crohn s and Colitis (2 papers)The American Journal of Gastroenterology (2 papers)Clinical Pharmacology & Therapeutics (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Kathleen Weisel
13 papers receiving 430 citations
Peers
Comparison fields: 5 of 51
- Immunology 172
- Genetics 134
- Hematology 40
- Molecular Biology 191
- Epidemiology 78
Countries citing papers authored by Kathleen Weisel
This map shows the geographic impact of Kathleen Weisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Weisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Weisel more than expected).
Fields of papers citing papers by Kathleen Weisel
This network shows the impact of papers produced by Kathleen Weisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Weisel. The network helps show where Kathleen Weisel may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathleen Weisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 138 | |
| 2 | 2017 | 109 | |
| 3 | 2021 | 66 | |
| 4 | 2020 | 62 | |
| 5 | 2013 | 30 | |
| 6 | 2022 | 18 | |
| 7 | HIGH CUT-OFF HAEMODIALYSIS (HCO-HD) DOES NOT IMPROVE OUTCOMES IN MYELOMA CAST NEPHROPATHY: RESULTS OF EUROPEAN TRIAL OF FREE LIGHT CHAIN REMOVAL BY EXTENDED HAEMODIALYSIS IN CAST NEPHROPATHY (EULITE) | 2016 | 6 |
| 8 | 2021 | 4 | |
| 9 | 2025 | 4 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2015 | 1 |
About Kathleen Weisel
Kathleen Weisel is a scholar working on Immunology, Molecular Biology, Genetics, Genetics and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 442 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Inflammatory Bowel Disease (3 papers), NF-κB Signaling Pathways (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Renal cell carcinoma treatment (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Immunology (172 citations), Genetics (134 citations), Hematology (40 citations), Molecular Biology (191 citations) and Epidemiology (78 citations). Kathleen Weisel has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Debra Tompson, John Bertin, Paul P. Tak, Monica Simeoni, Scott B. Berger, Nicola Scott, Zijiang Yang, Mary Ellen Frustaci, Anita Afzali and Julián Panés. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Clinical Pharmacology & Therapeutics and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.